Transient blindness following intravenous ondasetron [11]

Anaesthesia

Volumn 60, Issue 9, 2005, Pages 938-939

  Cherian, Abraham ^a   Maguire, M ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; FENTANYL; LYSERGIDE; NITROUS OXIDE; ONDANSETRON; OXYGEN; PROPOFOL; RABEPRAZOLE; SEVOFLURANE; SUXAMETHONIUM;

ABSCESS; ADULT; ASTHMA; ATHEROMA; CAROTID ARTERY OBSTRUCTION; CASE REPORT; CLINICAL FEATURE; DIZZINESS; DROWSINESS; DYSPNEA; ESOPHAGITIS; FEMALE; HEADACHE; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; LETTER; MYALGIA; PATIENT POSITIONING; POSTOPERATIVE NAUSEA AND VOMITING; PREOPERATIVE EVALUATION; SENSORY DYSFUNCTION; SHIVERING; SOMNOLENCE; SYMPTOMATOLOGY; TRANSITIONAL BLINDNESS; UNCONSCIOUSNESS; VISUAL IMPAIRMENT;

ADULT; ANTIEMETICS; BLINDNESS; FEMALE; HUMANS; ONDANSETRON; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE NAUSEA AND VOMITING;

EID: 23944476627     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2005.04348.x     Document Type: Letter

References (9)

1. GlaxoSmithKline [WWW document]. http://www.zofran.com/safety_ponv_iv.htm [accessed 25 May 2005].
2. Bosek V, Hu P, Robinson LA. Acute myocardial ischaemia after administration of ondansetron hydrochloride. Anaesthesiology 2000; 92: 885-7.
3. Kasinath NS, Malak O, Tetzlaff J. Atria] fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. Canadian Journal of Anaesthesia 2003; 50: 229-31.
4. Weiss KS. Anaphylactic reaction to ondansetron. Archives of International Medicine 2001; 161: 2263.
5. Sharma A, Raina V. Generalised seizures following ondansetron. Annals of Oncology 2001; 12: 131-2.
6. Anonymous. ASA Closed Claims Project [WWW document]. http://www.Departmentswashington,edu/asaccp/eye/providers/ instructional_booklet.pdf [accessed 25 May 2005].
7. Perez EA, Lembersky B, Kaywin P, et al. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy. The Cancer Journal from Scientific American 1998; 4: 52-8.
8. Pootanakit K, Brunken WJ. Identification of 5-HT (3A) and 5-HT (3B) receptor subunits in mammalian retinae: potential pre-synaptic modulators of photoreceptors. Brain Research 2001; 896: 77-85.
9. Hope AG, Peters JA, Brown AM, Lambert JJ, Blackburn TP. Characterisation of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) sub-unit stably expressed in HEK 293 cells. British Journal of Pharmacology 1996; 118: 1237-45.